The latest report by IMARC Group, titled “Hemodialysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“. offers a comprehensive analysis of the industry, which comprises insights on the global hemodialysis market growth. The global market size reached US$ 87.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 111.4 Billion by 2028, exhibiting a growth rate (CAGR) of 3.8% during 2023-2028.
Hemodialysis is a medical procedure used to remove waste products, excess fluids, and toxins from the blood when the kidneys are unable to perform their normal function adequately. It is a life-saving treatment for individuals with end-stage renal disease (ESRD) or acute kidney injury (AKI) who have lost a significant portion of their kidney function. It acts as an artificial replacement for kidney function, helping to maintain the body’s chemical balance. It helps to prevent complications related to kidney failure, such as fluid overload, electrolyte imbalances, and the accumulation of toxic substances in the blood. During hemodialysis, the patient’s blood is pumped out of their body through the access point and into a machine called a hemodialyzer or dialysis machine. The dialyzer contains a semipermeable membrane that separates the blood from a special dialysis fluid known as dialysate. Hemodialysis is typically performed three times a week, with each session lasting several hours. The exact duration and frequency depend on the patient’s specific needs and the recommendation of their healthcare team.
Request Your Sample Report Now: https://www.imarcgroup.com/hemodialysis-market/requestsample
Hemodialysis Market Trends and Drivers:
One of the primary drivers of the global hemodialysis market is the increasing incidence of chronic kidney diseases (CKD) and ESRD across the globe. Factors such as the aging population, sedentary lifestyles, and the prevalence of conditions like diabetes and hypertension have contributed to the growing pool of patients requiring renal replacement therapies. As healthcare systems strive to meet the rising demand for hemodialysis services, the market is witnessing consistent growth. Furthermore, technological advancements in hemodialysis machines and related equipment have revolutionized the treatment landscape, enhancing patient outcomes and improving the efficiency of the procedure. Innovations in dialysis machines have led to enhanced functionality, improved safety profiles, and streamlined treatment processes, thus garnering higher adoption rates among healthcare providers. In addition to technological progress, the global hemodialysis market is witnessing a positive trend in terms of increased access to healthcare facilities. Developing regions have been witnessing a rise in the establishment of dialysis centers, clinics, and hospitals equipped to provide hemodialysis services. The improvement in healthcare infrastructure, particularly in emerging economies, has made life-saving treatments like hemodialysis more accessible to a broader patient base. Moreover, a growing focus on research and development activities in the field of nephrology and hemodialysis has resulted in the introduction of novel therapies and dialysis products. Companies in the market are investing heavily in research and innovation to bring forth advanced hemodialysis solutions that cater to specific patient needs, further driving market growth.
Report Segmentation:
The report has segmented the market into the following categories:
- Breakup by Segment:
- Hemodialysis Product
- Machines
- Dialyzers
- Others
- Hemodialysis Service
- In-center Services
- Home Services
- Hemodialysis Product
Breakup by Modality:
- Conventional Hemodialysis
- Short Daily Hemodialysis
- Nocturnal Hemodialysis
Breakup by End User:
- Hospitals
- Independent Dialysis Centres
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Baxter International
- Asahi Kasei Corporation
- B. Barun Melsungen
- DaVita
- Cantel Medical Corporation
- Fresenius Medical Care
- Nipro Corporation
- Rockwell Medical
- Medivators
- Toray Medical Company Ltd.
- Nikkiso Co. Ltd.
- Surni Group
- Gambro
- Satellite Healthcare Inc.
- Renacon Pharma Ltd.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group
Email: [email protected]
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
About Author
